期刊文献+

慢病毒介导shRNA干扰前列腺癌PC3细胞Keap1基因表达的研究 被引量:1

Interference of shRNA on Keap1 in prostate cancer PC3 cell mediated by lentivirus
下载PDF
导出
摘要 目的:针对Keap1构建shRNA慢病毒干扰载体,并评价慢病毒介导的RNA干扰在人前列腺癌细胞PC3中的基因沉默效应。方法:利用生物信息学方法设计针对Keap1的RNAi寡聚核苷酸序列;采用慢病毒载体构建Keap1的shRNA载体,利用大肠杆菌进行重组表达,利用293T细胞包装得到重组腺病毒;依据绿色荧光蛋白(GFP)示踪,逐孔稀释法确定转染效率及滴度;以实时荧光定量法比较各靶序列的基因干扰效果。结果:筛选了所构建的4个Keap1靶向序列,以慢病毒载体构建完成对应Keap1的shRNA质粒。通过瞬时转染筛选得到效率最佳(干扰效率达到80%)的靶序列和工作条件。结论:本研究成功构建并筛选了针对Keap1的shRNA慢病毒载体,有效抑制PC3细胞中Keap1的表达。 AIM: To construct the shRNA in- terference lentivirus vector for Keapl and evalu- ate the interference effects in human prostate cancer PC3 cell mediated by lentivirus. METH- ODS: Bioinformatics methods were used to de- sign RNAi sequences for Keapl. A lentiviral vector was applied for construction of Keapl shRNA vectors, which was expressed in E. coli packaged by 293T cells. Transfection efficiency and titer were measured by dilution method ac- cording to the green fluorescent protein (GFP) tracer. Real-time fluorescence quantitative method was applied to compare interfere effects of target sequences. RESULTS: Four Keapl tar-geting sequences were constructed completely and the corresponding Keapl shRNA lentiviral vectors were screened for efficiency. One shR- NA lentiviral vector with best efficiency was screened by transient transfection (interference efficiency reached 80 %) and the working condi- tion was established as well. CONCLUSION. shRNA lentiviral vectors for Keapl was con- structed and screened successfully in PC3 cells, which effectively inhibit the expression of Keapl.
出处 《中国临床药理学与治疗学》 CAS CSCD 2014年第8期861-865,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金项目(81272485)
关键词 KEAP1 shRNA 慢病毒 PC3细胞 Keapl shRNA lentivirus PC3cell
  • 相关文献

参考文献13

  • 1Kobayashi M, Yamamoto M. Molecular mechanisms activating the Nrf2-Keapl pathway of an- tioxidant gene regulation[J]. Antioxid Redox Sig- nal, 2005,7(3/4) :385-394.
  • 2Jaramillo MC, Zhang DD. The emerging role of the Nrf2-Keapl signaling pathway in cancer[J]. Genes Dev, 2013,27(20) :2179-2191.
  • 3Niforou K, Cheimonidou C, Trougakos IP. Molec- ular chaperones and proteostasis regulation during redox imbalance[J]. Redox Biol, 2014,2:323-332.
  • 4Kansanen E, Kuosmanen SM, Leinonen H, et al. The Keapl-Nrf2 pathway: Mechanisms of activa- tion and dysregulation in cancer[J]. Redox Biol, 2013,1(1) :45-49.
  • 5Jayakumar S, Kunwar A, Sandur SK, et al. Differ- ential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity[J]. Bio- chim Biophys Acta, 2014,1840(1) :485-494.
  • 6Pettazzoni P, Ciamporcero E, Medana C, et al. Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells[J]. Free Radic Biol Med, 2011,51 (8): 1610-1618.
  • 7Magesh S, Chen Y, Hu L. Small molecule modula- tors of Keapl-Nrf2 ARE pathway as potential pre- ventive and therapeutic agents[J]. Med Res Rev,2012,32(4):687-726.
  • 8Zhang P, Singh A, Yegnasubramanian S, et al. Loss of Kelch-like ECH-associated protein 1 func- tion in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth [J]. Mol Cancer Ther, 2010,9(2) :336-346.
  • 9Yoo NJ, Kim HR, Kim YR, et al. Somatic muta- tions of the KEAP1 gene in common solid cancers [J]. Histopathology, 2012,60(6) :943-952.
  • 10Xu Y, Fang F, Miriyala S, et al. KEAP1 is a redox sensitive target that arbitrates the opposing radio- sensitive effects of parthenolide in normal and canc ercells[J]. Cancer Res,2013,73(14):4406-4417.

同被引文献23

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部